Pegozafermin provides beneficial lipid effects in subjects with severe hypertriglyceridemia regardless of background lipid modifying therapy status: an analysis of the phase 2 entrigue study
Journal of the American College of Cardiology（2023）
Key words
severe hypertriglyceridemia
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined